David M. Sabatini
Molecular Biology · 2001–2020
A researcher in the Science corpus: 59 papers; trusts 166 researchers and is trusted by 194 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 1,032 citations into it; #97 of 17,836 by trust here, #48 by citations
- Physiology — 283 citations into it
- Cancer Research — 172 citations into it; #176 of 1,784 by trust here, #277 by citations
- Epidemiology — 134 citations into it
- Cell Biology — 125 citations into it; #129 of 2,073 by trust here, #28 by citations
- Oncology — 109 citations into it; #259 of 1,698 by trust here, #501 by citations
- Immunology — 99 citations into it; #942 of 2,162 by trust here, #517 by citations
- Aging — 98 citations into it
Whom David M. Sabatini trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- K. Inoki
- Dos D. Sarbassov
- Y. Sancak
- B. Manning
- Timothy R. Peterson
- C. Thoreen
- Siraj M. Ali
- D. Guertin
- L. Bar-Peled
- E. Jacinto
Who trusts David M. Sabatini overall
- M. Laplante
- Shijie Li
- Y. Sancak
- R. A. Saxton
- L. Bar-Peled
- Timothy R. Peterson
- T. Franke
- D. Morrison
- A. Budanov
- Roberto Zoncu
Papers from David M. Sabatini's perspective
Ordered by how strongly the researchers David M. Sabatini trusts endorse each paper. Same corpus, a different order for every researcher.
- TOR signaling in growth and metabolism. (Cell)
- TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (Science)
- mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (Cell)
- TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (Nature Cell Biology)
- Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. (Molecules and Cells)
- Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. (Molecules and Cells)
- Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling (Nature Cell Biology)
- Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. (Cell)
- Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. (Current Biology)
Their papers
- mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (2002) — 3,106 citations
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (2005) — 5,749 citations
- Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. (2006) — 2,823 citations
- Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. (2004) — 2,819 citations
- Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. (2006) — 1,535 citations
- Defining the role of mTOR in cancer. (2007) — 2,978 citations
- PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. (2007) — 1,314 citations
- A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. (2006) — 1,888 citations
- The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 (2008) — 2,809 citations
- mTOR and cancer: insights into a complex relationship (2006) — 1,384 citations
- mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the Vacuolar H+-ATPase (2011) — 1,614 citations
- Growing roles for the mTOR pathway. (2005) — 1,640 citations
- Genetic Screens in Human Cells Using the CRISPR-Cas9 System (2013) — 2,804 citations
- CellProfiler: image analysis software for identifying and quantifying cell phenotypes (2006) — 5,206 citations
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* (2009) — 1,819 citations
- GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. (2003) — 1,012 citations
- mTOR signaling in growth control and disease (2012) — 8,358 citations
- Cancer cell metabolism: Warburg and beyond. (2008) — 2,366 citations
- mTOR: from growth signal integration to cancer, diabetes and ageing (2010) — 4,005 citations
- Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids (2010) — 2,430 citations